Tilman Hensch

Prof. Dr. Tilman Hensch

Department of Psychiatry and Psychotherapy, University of Leipzig, 04103 Leipzig, Germany
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MLMarkus Loeffler
Markus Loeffler
CEChristoph Engel
Christoph Engel
PAPeter Ahnert
Peter Ahnert
DADorothee Alfermann
Dorothee Alfermann
KAKatrin Arelin
Katrin Arelin
JTJoachim Thiery
Joachim Thiery
The LIFE-Adult-Study is a population-based cohort study, which has recently completed the baseline examination of 10,000 randomly selected participants from Leipzig, a major city with 550,000 inhabitants in the east of Germany. It is the first study of this kind and size in an urban population in the eastern part of Germany. The study is conducted by the Leipzig Research Centre for Civilization Diseases (LIFE). Our objective is to investigate prevalences, early onset markers, genetic predispositions, and the role of lifestyle factors of major civilization diseases, with primary focus on metabolic and vascular diseases, heart function, cognitive impairment, brain function, depression, sleep disorders and vigilance dysregulation, retinal and optic nerve degeneration, and allergies. The study covers a main age range from 40-79 years with particular deep phenotyping in elderly participants above the age of 60. The baseline examination was conducted from August 2011 to November 2014. All participants underwent an extensive core assessment programme (5-6 h) including structured interviews, questionnaires, physical examinations, and biospecimen collection. Participants over 60 underwent two additional assessment programmes (3-4 h each) on two separate visits including deeper cognitive testing, brain magnetic resonance imaging, diagnostic interviews for depression, and electroencephalography. The participation rate was 33 %. The assessment programme was accepted well and completely passed by almost all participants. Biomarker analyses have already been performed in all participants. Genotype, transcriptome and metabolome analyses have been conducted in subgroups. The first follow-up examination will commence in 2016.

1 December 2013 in NeuroImage
Verified
Journal Article
Closed access
JJJorge Jovicich
Jorge Jovicich
MMMoira Marizzoni
Moira Marizzoni
RSRoser Sala-Llonch
Roser Sala-Llonch
BBBeatriz Bosch
Beatriz Bosch
DBDavid Bartrés-Faz
David Bartrés-Faz
GFGiovanni B. Frisoni
Giovanni B. Frisoni

1 July 2014 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
UHUlrich Hegerl
Ulrich Hegerl
Tilman HenschTilman Hensch
Tilman Hensch

4 October 2011 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
VDValeria Drago
Valeria Drago
Claudio BabiloniClaudio Babiloni
Claudio Babiloni
DBDavid Bartrés-Faz
David Bartrés-Faz
ACAnna Caroli
Anna Caroli
BBBeatriz Bosch
Beatriz Bosch
GFGiovanni B. Frisoni
Giovanni B. Frisoni
Older persons with Mild Cognitive Impairment (MCI) feature neurobiological Alzheimer's Disease (AD) in 50% to 70% of the cases and develop dementia within the next 5 to 7 years. Current evidence suggests that biochemical, neuroimaging, electrophysiol

1 January 2016 in NeuroImage
Verified
Journal Article
Closed access
JJJorge Jovicich
Jorge Jovicich
LMLudovico Minati
Ludovico Minati
MMMoira Marizzoni
Moira Marizzoni
RMRocco Marchitelli
Rocco Marchitelli
RSRoser Sala-Llonch
Roser Sala-Llonch
GFGiovanni B. Frisoni
Giovanni B. Frisoni

29 December 2022 in NeuroImage
Verified
Journal Article
Open access
ECElena Cesnaite
Elena Cesnaite
PSPaul Steinfath
Paul Steinfath
MIMina Jamshidi Idaji
Mina Jamshidi Idaji
TSTilman Stephani
Tilman Stephani
DKDeniz Kumral
Deniz Kumral
VNVadim V. Nikulin
Vadim V. Nikulin
While many structural and biochemical changes in the brain have previously been associated with older age, findings concerning functional properties of neuronal networks, as reflected in their electrophysiological signatures, remain rather controversial. These discrepancies might arise due to several reasons, including diverse factors determining general spectral slowing in the alpha frequency range as well as amplitude mixing between the rhythmic and non-rhythmic parameters. We used a large dataset (N = 1703, mean age 70) to comprehensively investigate age-related alterations in multiple EEG biomarkers taking into account rhythmic and non-rhythmic activity and their individual contributions to cognitive performance. While we found strong evidence for an individual alpha peak frequency (IAF) decline in older age, we did not observe a significant relationship between theta power and age while controlling for IAF. Not only did IAF decline with age, but it was also positively associated with interference resolution in a working memory task primarily in the right and left temporal lobes suggesting its functional role in information sampling. Critically, we did not detect a significant relationship between alpha power and age when controlling for the 1/f spectral slope, while the latter one showed age-related alterations. These findings thus suggest that the entanglement of IAF slowing and power in the theta frequency range, as well as 1/f slope and alpha power measures, might explain inconsistencies reported previously in the literature. Finally, despite the absence of age-related alterations, alpha power was negatively associated with the speed of processing in the right frontal lobe while 1/f slope showed no consistent relationship to cognitive performance. Our results thus demonstrate that multiple electrophysiological features, as well as their interplay, should be considered for the comprehensive assessment of association between age, neuronal activity, and cognitive performance.